D-575-2013 Class III Terminated

Recalled by Novartis Consumer Health — Lincoln, NE

FDA drug recall D-575-2013 was initiated by Novartis Consumer Health on Feb 19, 2013 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot. The recall status is terminated (terminated Nov 26, 2014). Affected quantity: 219,600 tubes.

Recall details

Product Type
Drugs
Report Date
Jun 12, 2013
Initiation Date
Feb 19, 2013
Termination Date
Nov 26, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
219,600 tubes

Product description

Novartis Lamisil AT Cream for Jock Itch (terbinafine hydrochloride 1% antifungal), a) 12 g (.42 oz) Tube, NDC 0067-3999-12, Novartis Consumer Health, Inc., Parsitan, NJ. UPC code: 300673999121, (Vertical Pack) and b) packaged in a horizontal package12 gm (.42 oz) Tube, NDC 0067-3999-42, Novartis Consumer Health, Inc., Parsippany, NJ. UPC code: 300673999428.

Reason for recall

Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot.

Distribution pattern

Nationwide and Puerto Rico, and Panama. Military distribution made.

Code information

Lot number and exp date: 10104145 30-Apr-2013. (Vertical package) and Lot number and exp date: 10109587 30-Apr-2013, 10111508 31-May-2013; 10119095 31-Jul-2013 and 10119096 30-Sep-2013 (Horizontal package).

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-575-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-575-2013. Report a data issue: hello@regdatalab.com.